New Delhi: Having yielded encouraging results in the initial phases of its trial, one of the three COVID-19 vaccine candidates would enter the third phase of the pre-clinical human trial by Wednesday, informed the Ministry of Health and Family Welfare on Tuesday.
Head of the national task force on COVID-19, Dr. V.K. Paul informed about the development during a weekly press briefing, said media reports.
While not sharing the names of the other two vaccines, Paul added that they are currently in phase-I or II of their pre-clinical trials.
India has three vaccine candidates for COVID-19 – ChAdOx1, developed by Oxford University and manufactured jointly by the Serum Institute of India (SII), Pune and AstraZeneca, Bharat Biotech’s Covaxin, jointly developed with the Indian Council of Medical Research and the third is ZycovD by Zydus Cadila.
Mumbai: Bollywood celebrities have often had funny, at times bizarre experiences, mostly involving hero-worshipping, demanding fans.…
Bhubaneswar: Police have arrested the owner of a Jatra (theatre) group for allegedly duping an…
Sanskriti Talwar Faridkot (Punjab): For the third consecutive year, Balwinder Singh of Mallan village in…
Bhubaneswar: Rain may play spoilsport in Christmas and New Year celebrations in Odisha as the…
New Delhi: Netflix showed the way, Amazon Prime Video is following in their footsteps. Come…
Hyderabad: Allu Arjun’s woes keep mounting. In a worrying development, protesters stormed Allu Arjun’s Jubilee…
This website uses cookies.